Physician profile
Kathryn Score
NPI 1083091169
$879.44
in general payments reported to CMS, 2019-2025
16 companies · $280 in 2025
The $280 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2023: $40.63 · 2024: $242 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $562.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $561.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $158.54 | 2019-2025 | Evenity, Prolia |
| Astrazeneca Pharmaceuticals LP | $135.87 | 2019 | |
| Novo Nordisk INC | $97.79 | 2019-2025 | Ozempic, Rybelsus |
| Astellas Pharma US INC | $86.29 | 2025 | Veozah |
| Daiichi Sankyo INC. | $80.07 | 2023-2024 | Injectafer |
| Pfizer INC. | $58.17 | 2024-2025 | |
| Organon LLC | $52.35 | 2024-2025 | Nexplanon |
| Lilly USA, LLC | $42.29 | 2023-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $39.47 | 2019 | |
| Hologic Sales and Service, LLC | $24.74 | 2025 | Thinprep 2000 Processor |
| Pharmacosmos Therapeutics INC. | $20.45 | 2024 | Monoferric |
| Radius Health, INC. | $19.30 | 2024 | Tymlos |
| Sumitomo Pharma America, INC. | $18.97 | 2025 | Gemtesa |
| Pelvital USA, INC. | $17.53 | 2025 | |
| Dexcom, INC. | $15.13 | 2025 | Dexcom G6 Transmitter |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $12.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Score listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.